Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2
- PMID: 12626908
- DOI: 10.1007/s10350-004-6552-y
Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2
Abstract
Purpose: The aims of this study were to determine the rate of lymph node micrometastases and to evaluate their prognostic value in lateral lymph nodes in lower rectal cancer at or below the peritoneal reflection.
Methods: A retrospective analysis was made of 892 lymph nodes from 66 consecutive patients who had undergone radical resection with lateral lymph node dissection. These lymph nodes were examined immunohistochemically with an antibody against cytokeratins 7 and 8, CAM5.2.
Results: Routine hematoxylin-eosin staining revealed 9 patients with positive lateral lymph nodes that were stained consistently with CAM5.2. Among 57 patients in whom lateral lymph node metastases were not detected by hematoxylin-eosin staining, cytokeratin staining was positive in 19 nodes (2.7 percent) from 11 patients (19.3 percent). These 11 patients with micrometastases in lateral nodes showed a significantly high recurrence rate (P = 0.048) and worse overall survival (P = 0.01) than the 46 patients without lateral node metastases. The recurrence rate and overall survival of patients with micrometastases did not differ significantly from those of patients with positive lateral nodes with hematoxylin-eosin staining. Local recurrence developed in 6 of 66 patients, but neither the presence nor the absence of micrometastases in lateral nodes influenced the local recurrence rate.
Conclusion: The presence of nodal micrometastases leads to a poor prognosis. The survival of patients with micrometastases was not different from that of patients with overt metastases. Therefore, patients with cytokeratin-positive cells in lateral lymph nodes should be regarded as having overt metastases.
Similar articles
-
Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody.Cancer. 1999 Apr 1;85(7):1465-9. doi: 10.1002/(sici)1097-0142(19990401)85:7<1465::aid-cncr6>3.0.co;2-t. Cancer. 1999. PMID: 10193935 Clinical Trial.
-
Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.Dis Colon Rectum. 2016 May;59(5):396-402. doi: 10.1097/DCR.0000000000000567. Dis Colon Rectum. 2016. PMID: 27050601
-
Lymph node micrometastases do not predict relapse in stage II colon cancer.Ann Surg Oncol. 2000 Sep;7(8):601-8. doi: 10.1007/BF02725340. Ann Surg Oncol. 2000. PMID: 11005559
-
Is the lateral lymph node compartment relevant?Recent Results Cancer Res. 2005;165:40-5. doi: 10.1007/3-540-27449-9_6. Recent Results Cancer Res. 2005. PMID: 15865019 Review.
-
The Landmark Series: Management of Lateral Lymph Nodes in Locally Advanced Rectal Cancer.Ann Surg Oncol. 2020 Aug;27(8):2723-2731. doi: 10.1245/s10434-020-08639-8. Epub 2020 Jun 9. Ann Surg Oncol. 2020. PMID: 32519144 Review.
Cited by
-
Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.Int J Colorectal Dis. 2010 Mar;25(3):359-68. doi: 10.1007/s00384-009-0864-2. Epub 2009 Dec 10. Int J Colorectal Dis. 2010. PMID: 20012295
-
Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer.World J Surg. 2016 Jun;40(6):1492-9. doi: 10.1007/s00268-016-3444-y. World J Surg. 2016. PMID: 26908236
-
Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.Int J Colorectal Dis. 2016 Jul;31(7):1315-21. doi: 10.1007/s00384-016-2607-5. Epub 2016 May 30. Int J Colorectal Dis. 2016. PMID: 27240821
-
Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.Mol Clin Oncol. 2013 Jul;1(4):582-592. doi: 10.3892/mco.2013.116. Epub 2013 May 9. Mol Clin Oncol. 2013. PMID: 24649214 Free PMC article. Review.
-
Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection.Cancers (Basel). 2021 Oct 21;13(21):5294. doi: 10.3390/cancers13215294. Cancers (Basel). 2021. PMID: 34771458 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous